Oruka Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-4.3M | $-4.3M | $2.0K | $167.0K |
| Jun 2022 | $-2.6M | $-2.6M | $0 | — |
| Sep 2022 | $-2.5M | $-2.5M | $0 | — |
| Mar 2023 | $-1.6M | $-1.6M | — | $204.0K |
| Jun 2023 | $-694.0K | $-694.0K | — | — |
| Sep 2023 | $-1.7M | $-1.7M | — | — |
| Mar 2024 | $-1.5M | $-1.5M | — | $114.0K |
| Jun 2024 | $-2.6M | $-2.6M | — | — |
| Mar 2025 | $-20.9M | $-20.9M | $13.0K | $4.9M |
| Jun 2025 | $-23.1M | $-23.2M | $34.0K | — |
| Sep 2025 | $-21.6M | $-21.7M | $99.0K | — |
| Mar 2026 | $-23.6M | $-23.7M | $73.0K | $7.0M |
| Jun 2026 | $-33.1M | $-33.1M | $0 | — |